{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T05:01:38Z","timestamp":1785042098735,"version":"3.55.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["SALUD-2016-272579"],"award-info":[{"award-number":["SALUD-2016-272579"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["TA200515"],"award-info":[{"award-number":["TA200515"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.rgmxen.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T15:22:26Z","timestamp":1679757746000},"page":"136-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver disease"],"prefix":"10.1016","volume":"88","author":[{"given":"M.","family":"Martinez-Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Altamirano-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Garc\u00eda-Islas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"S\u00e1nchez-Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hern\u00e1ndez-Santill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hern\u00e1ndez-Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"P\u00e9rez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Higuera-de la Tijera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gutierrez-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2023.03.003_bib0005","first-page":"1","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0035-1550054","article-title":"Liver fibrosis in alcoholic liver disease","volume":"35","author":"Bataller","year":"2015","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0015","series-title":"Encuesta nacional de consumo de drogas, alcohol y tabaco. 1","first-page":"190","author":"Villatoro-Vel\u00e1zquez","year":"2017"},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1176\/appi.ajp.157.5.745","article-title":"Age at first alcohol use: a risk factor for the development of alcohol disorders","volume":"157","author":"DeWit","year":"2000","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0025","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1542\/peds.2006-0223","article-title":"Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment","volume":"118","author":"Hingson","year":"2006","journal-title":"Pediatrics."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11920-019-1008-1","article-title":"Genetics of alcoholism","volume":"21","author":"Edenberg","year":"2019","journal-title":"Curr Psychiatry Rep."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.15288\/jsad.2009.70.623","article-title":"A comparison of diagnoses obtained from in-person and telephone interviews, using the semi-structured assessment for the genetics of alcoholism (SSAGA)","volume":"70","author":"Kramer","year":"2009","journal-title":"J Stud Alcohol Drugs."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1665-2681(19)32122-2","article-title":"Etiology of liver cirrhosis in Mexico","volume":"3","author":"M\u00e9ndez-S\u00e1nchez","year":"2004","journal-title":"Ann Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0045","unstructured":"Transmisibles DdVEdEN. Panorama epidemiol\u00f3gico de las enfermedades no transmisibles en M\u00e9xico | Secretar\u00eda de Salud | Gobierno | gob.mx. 2021 Available from: https:\/\/www.gob.mx\/salud\/documentos\/panorama-epidemiologico-de-las-emferemedades-no-transmisibles-en-mexico-269304."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1665-2681(19)32086-1","article-title":"Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data","volume":"4","author":"M\u00e9ndez-S\u00e1nchez","year":"2005","journal-title":"Ann Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0055","doi-asserted-by":"crossref","first-page":"922","DOI":"10.12998\/wjcc.v6.i15.922","article-title":"Current trends of liver cirrhosis in Mexico: similitudes and differences with other world regions","volume":"6","author":"M\u00e9ndez-S\u00e1nchez","year":"2018","journal-title":"World J Clin Cases."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.524356","article-title":"Mortality from alcohol-related liver cirrhosis in Mexico (2000-2017)","volume":"8","author":"Yeverino-Guti\u00e9rrez","year":"2020","journal-title":"Front Public Health."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cld.806","article-title":"Epidemiology of alcohol use and alcoholic liver disease","volume":"13","author":"Mellinger","year":"2019","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1515\/jtim-2017-0003","article-title":"Early detection of liver damage in Mexican patients with chronic liver disease","volume":"5","author":"Torres-Valadez","year":"2017","journal-title":"J Transl Int Med."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000343840","article-title":"Delayed diagnosis of HCC with chronic alcoholic liver disease","volume":"1","author":"Sch\u00fctte","year":"2012","journal-title":"Liver Cancer."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13311-019-00802-8","article-title":"Diagnosis and management of alcohol use disorder in patients with liver disease: lights and shadows","volume":"17","author":"Addolorato","year":"2020","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5009\/gnl16477","article-title":"Pathophysiology and management of alcoholic liver disease: Update 2016","volume":"11","author":"Stickel","year":"2017","journal-title":"Gut Liver."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0090","unstructured":"Diario Oficial de la Federaci\u00f3n. Norma Oficial Mexicana NOM-047-SSA2-2015, para la atenci\u00f3n a la salud del grupo etario de 10 a 19 a\u00f1os de edad. 2015. Available from: https:\/\/www.gob.mx\/salud\/documentos\/nom-047-ssa2-2015-para-la-atencion-a-la-salud-del-grupo-etario-de-10-a-19-anos-de-edad."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10654-011-9631-0","article-title":"Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis","volume":"26","author":"Costanzo","year":"2011","journal-title":"Eur J Epidemiol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/STROKEAHA.111.639435","article-title":"Alcohol consumption and risk of stroke in women","volume":"43","author":"Jim\u00e9nez","year":"2012","journal-title":"Stroke."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.numecd.2016.03.007","article-title":"Effects of moderate beer consumption on health and disease: a consensus document","volume":"26","author":"De Gaetano","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0115","series-title":"AUDIT - The alcohol use disorders identification test: guidelines for use in primary care","first-page":"4","author":"Babor","year":"2001"},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0120","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1080\/10826084.2020.1768549","article-title":"Longitudinal impact of life events on adolescent binge drinking in the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA)","volume":"55","author":"Nooner","year":"2020","journal-title":"Subst Use Misuse."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"64","author":"Hasin","year":"2007","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O\u2019Shea","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cld.2016.02.003","article-title":"Unhealthy alcohol use","volume":"20","author":"Holt","year":"2016","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0025-7753(04)74463-2","article-title":"Estudio de validaci\u00f3n de la escala multidimensional de craving de alcohol","volume":"123","author":"Guardia-Serecigni","year":"2004","journal-title":"Med Cl\u00edn."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0145","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.4254\/wjh.v7.i27.2703","article-title":"Binge drinking: burden of liver disease and beyond","volume":"7","author":"Llerena","year":"2015","journal-title":"World J Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0155","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/alcalc\/agz036","article-title":"Alcoholic hepatitis: a review","volume":"54","author":"Hosseini","year":"2019","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0160","doi-asserted-by":"crossref","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","article-title":"Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0165","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.3390\/ijms22115717","article-title":"Pathophysiological aspects of alcohol metabolism in the liver","volume":"22","author":"Hyun","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/biomedicines6040106","article-title":"Alcoholic liver disease: alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects","volume":"6","author":"Teschke","year":"2018","journal-title":"Biomedicines."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0175","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.yexmp.2015.09.001","article-title":"Alcoholic liver disease: clinical and translational research","volume":"99","author":"Neuman","year":"2015","journal-title":"Exp Mol Pathol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0180","first-page":"135","article-title":"The role of oxidative stress in the development of alcoholic liver disease","volume":"79","author":"Galicia-Moreno","year":"2014","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cld.2016.02.002","article-title":"Spectrum of alcoholic liver disease","volume":"20","author":"Chacko","year":"2016","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0190","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","article-title":"Trends in the management and burden of alcoholic liver disease","volume":"62","author":"Mathurin","year":"2015","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0195","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMra1715733","article-title":"Alcohol use in patients with chronic liver disease","volume":"379","author":"Fuster","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0200","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1782157","article-title":"Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans","volume":"12","author":"Maccioni","year":"2020","journal-title":"Gut Microbes."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0205","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cld.2016.02.004","article-title":"Pathogenesis of alcoholic liver disease","volume":"20","author":"Dunn","year":"2016","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0210","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol Clin Exp Res."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0215","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrgastro.2017.116","article-title":"Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations","volume":"15","author":"Parker","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-2275(20)40613-3","article-title":"Effects of ethanol on lipid metabolism","volume":"20","author":"Baraona","year":"1979","journal-title":"J Lipid Res."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0225","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1074\/jbc.273.1.302","article-title":"Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells","volume":"273","author":"Wang","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.14218\/JCTH.2017.00061","article-title":"Role of SREBPs in liver diseases: a mini-review","volume":"6","author":"Moslehi","year":"2018","journal-title":"J Clin Transl Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1530-0277.2008.00827.x","article-title":"Molecular mechanisms of alcoholic fatty liver","volume":"33","author":"Purohit","year":"2009","journal-title":"Alcohol Clin Exp Res."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0240","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/j.gastro.2004.09.049","article-title":"The role of AMP-activated protein kinase in the action of ethanol in the liver","volume":"127","author":"You","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0245","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajpath.2011.11.017","article-title":"Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis","volume":"180","author":"Zhong","year":"2012","journal-title":"Am J Pathol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0250","doi-asserted-by":"crossref","first-page":"35989","DOI":"10.1074\/jbc.M111.254201","article-title":"Identification of a cytochrome P4502E1\/Bid\/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice","volume":"286","author":"Sebastian","year":"2011","journal-title":"J Biol Chem."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0255","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bpg.2010.07.003","article-title":"Alcoholic steatohepatitis","volume":"24","author":"Stickel","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0260","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4254\/wjh.v9.i8.418","article-title":"Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver","volume":"9","author":"Schneider","year":"2017","journal-title":"World J Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0265","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.510310118","article-title":"Hydrogen peroxide: a link between acetaldehyde-elicited alpha 1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells","volume":"31","author":"Greenwel","year":"2000","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.20798","article-title":"Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent","volume":"42","author":"Svegliati-Baroni","year":"2005","journal-title":"Hepatolog."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0280","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.gastro.2007.09.034","article-title":"Abrogation of the antifibrotic effects of natural killer cells\/interferon-\u03b3 contributes to alcohol acceleration of liver fibrosis","volume":"134","author":"Jeong","year":"2008","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0285","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.1074\/jbc.M110506200","article-title":"Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells","volume":"277","author":"Nieto","year":"2002","journal-title":"J Biol Chem."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0290","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/hep.21107","article-title":"Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium","volume":"43","author":"Purohit","year":"2006","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0295","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology (Baltimore, Md)."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0300","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2004.03.007","article-title":"Cirrhosis reversal: a duel between dogma and myth","volume":"40","author":"Desmet","year":"2004","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0305","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0310","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0315","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0320","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2018.10.026","article-title":"Current trials and novel therapeutic targets for alcoholic hepatitis","volume":"70","author":"Singal","year":"2019","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0330","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0335","article-title":"IL-1 Receptor antagonist in combination with Pentoxifylline and Zinc for severe alcoholic hepatitis: a multicenter randomized double-bind placebo-controlled clinical trial","volume":"68","author":"Szabo","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0340","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S2468-1253(19)30326-7","article-title":"The Knowns and unknowns of treatment for alcoholic hepatitis","volume":"5","author":"Sehrawat","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0345","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0350","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0355","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0360","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1478-3231.2011.02604.x","article-title":"Antioxidants as therapeutic agents for liver disease","volume":"31","author":"Singal","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0365","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-Acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0370","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1665-2681(19)30863-4","article-title":"Treatment with Metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis","volume":"13","author":"Higuera-de la Tijera","year":"2014","journal-title":"Ann Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0375","first-page":"25","article-title":"Trasplante hep\u00e1tico en M\u00e9xico","volume":"7","author":"Mendoza-S\u00e1nchez","year":"2018","journal-title":"Rev Mex Traspl."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0380","first-page":"455","article-title":"Liver transplantation in Mexican older adults: a comparative single-center study","volume":"84","author":"Hern\u00e1ndez-Ruiz","year":"2019","journal-title":"Rev Gastroenterol Mex (Engl Ed)."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0385","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/alcalc\/ags041","article-title":"TH-1 and TH-2 cytokines in stable chronic alcoholics","volume":"47","author":"Gonz\u00e1lez-Reimers","year":"2012","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0390","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1152\/ajpregu.00340.2007","article-title":"Endotoxin downregulates peroxisome proliferator-activated receptor-\u03b3 via the increase in TNF-\u03b1 release","volume":"294","author":"Zhou","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0395","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","article-title":"IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses","volume":"101","author":"Xing","year":"1998","journal-title":"J Clin Invest."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0400","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.4049\/jimmunol.164.9.4878","article-title":"IL-6 is required for the development of Th1 cell-mediated murine colitis","volume":"164","author":"Yamamoto","year":"2000","journal-title":"J Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0405","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.175.6.3463","article-title":"Directing transition from innate to acquired immunity: defining a role for IL-6","volume":"175","author":"Jones","year":"2005","journal-title":"J Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0410","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1074-7613(01)00151-0","article-title":"IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation","volume":"14","author":"Hurst","year":"2001","journal-title":"Immunity."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0415","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1471-4906(02)00013-3","article-title":"IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation","volume":"24","author":"Kaplanski","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0420","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/495156","article-title":"The effect of inflammatory cytokines in alcoholic liver disease","volume":"2013","author":"Kawaratani","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0425","first-page":"547","article-title":"Increased plasma interleukin-6 concentrations in alcoholic hepatitis","volume":"119","author":"Hill","year":"1992","journal-title":"J Lab Clin Med."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0430","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.onc.1205016","article-title":"Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins","volume":"21","author":"Hong","year":"2002","journal-title":"Oncogene."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0435","first-page":"449","article-title":"Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis","volume":"84","author":"Sheron","year":"1991","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0440","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1053\/he.2000.7013","article-title":"Ethanol potentiates tumor necrosis factor-\u03b1 cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition","volume":"31","author":"Pastorino","year":"2000","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0445","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/hep.1840140627","article-title":"Kupffer cell\u2013derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures","volume":"14","author":"Thornton","year":"1991","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0450","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dom\u00ednguez","year":"2009","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0455","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0460","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","article-title":"Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity","volume":"132","author":"Colmenero","year":"2007","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0465","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0470","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J Clin Invest."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0475","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jhep.2014.12.027","article-title":"Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1\u03b2 in mice","volume":"62","author":"Cui","year":"2015","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0480","first-page":"823","article-title":"Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents","volume":"37","author":"Fertin","year":"1991","journal-title":"Cell Mol Biol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0485","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0490","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI741","article-title":"Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma","volume":"101","author":"Doucet","year":"1998","journal-title":"J Clin Invest."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0495","first-page":"307","article-title":"Collagen synthesis by human liver (myo)fibroblasts in culture: evidence fora regulatory role of IL-1\u03b2,IL-4, TGF\u03b2 and IFN gamma","volume":"23","author":"Tiggelman","year":"1995","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0500","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2003","journal-title":"Annu Rev Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0505","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0510","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.510300144","article-title":"Transforming growth factor \u03b2 and tumor necrosis factor \u03b1 inhibit both apoptosis and proliferation of activated rat hepatic stellate cells","volume":"30","author":"Saile","year":"1999","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0515","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.24388","article-title":"Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis","volume":"54","author":"Tarrats","year":"2011","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0520","first-page":"205","article-title":"IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver","volume":"205","author":"El-Assal","year":"2004","journal-title":"Cell Mol Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0525","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cytogfr.2018.01.002","article-title":"Interleukin-6: a promising cytokine to support liver regeneration and adaptive immunity in liver pathologies","volume":"39","author":"Naseem","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0530","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3748\/wjg.v12.i16.2563","article-title":"Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma","volume":"12","author":"Soresi","year":"2006","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0535","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yexmp.2017.08.005","article-title":"The role of the IL-8 signaling pathway in the infiltration of granulocytes into the livers of patients with alcoholic hepatitis","volume":"103","author":"French","year":"2017","journal-title":"Exp Mol Pathol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0540","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.4049\/jimmunol.168.9.4559","article-title":"Signaling pathways involved in IL-8-dependent activation of adhesion through Mac-1","volume":"168","author":"Takami","year":"2002","journal-title":"J Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021381","article-title":"Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PloS One."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0550","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.alcohol.2011.10.001","article-title":"Changes in cytokine levels during admission and mortality in acute alcoholic hepatitis","volume":"46","author":"Gonz\u00e1lez-Reimers","year":"2012","journal-title":"Alcohol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0555","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J Exp Med."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0560","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3389\/fimmu.2017.01414","article-title":"Suppression of natural killer cell activity by regulatory NKT10 cells aggravates alcoholic hepatosteatosis","volume":"8","author":"Cui","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0565","article-title":"IFN-\u03b3 deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet","volume":"305","author":"Luo","year":"2013","journal-title":"Ame J Physiol Gastrointest Liver Physiol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0570","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/hep4.1364","article-title":"Deficient IL\u20106\/Stat3 Signaling, High TLR7, and Type I Interferons in early human alcoholic liver disease: a triad for liver damage and fibrosis","volume":"3","author":"St\u00e4rkel","year":"2019","journal-title":"Hepatol Commun."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0575","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.21344","article-title":"STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice","volume":"44","author":"Sun","year":"2006","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0580","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.21419","article-title":"STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity","volume":"44","author":"Jeong","year":"2006","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0585","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor\u2013related apoptosis-inducing ligand\u2013dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0590","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0595","first-page":"1292","article-title":"Effects of 18\u03b1-glycyrrhizin on TGF-\u03b21\/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis","volume":"8","author":"Qu","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0600","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1074\/jbc.M111.314922","article-title":"Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury","volume":"287","author":"Zhang","year":"2012","journal-title":"J Biol Chem."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0605","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.24599","article-title":"An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice","volume":"54","author":"Mandrekar","year":"2011","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0610","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gut.45.3.416","article-title":"Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease","volume":"45","author":"Fisher","year":"1999","journal-title":"Gut."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0615","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hep.26115","article-title":"Natural killer cells in liver disease","volume":"57","author":"Tian","year":"2013","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0620","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbadis.2012.09.008","article-title":"Natural killer and natural killer T cells in liver fibrosis","volume":"1832","author":"Gao","year":"2013","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0625","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0630","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hep.23320","article-title":"Natural killer group 2 member D, its ligands, and liver disease: good or bad?","volume":"51","author":"Gao","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0635","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/hep.23253","article-title":"Major histocompatibility complex class I\u2013related chains A and B (MIC A\/B): a novel role in nonalcoholic steatohepatitis","volume":"51","author":"Kahraman","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0640","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.21872","article-title":"Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells","volume":"46","author":"Chen","year":"2007","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0645","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/jhep.2001.26517","article-title":"Factors affecting liver fibrosis in human immunodeficiency virus\u2013and hepatitis C virus\u2013coinfected patients: impact of protease inhibitor therapy","volume":"34","author":"Benhamou","year":"2001","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0650","doi-asserted-by":"crossref","first-page":"s47","DOI":"10.1002\/hep.1840360707","article-title":"Fibrosis and disease progression in hepatitis C","volume":"36","author":"Marcellin","year":"2002","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0655","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/hep.25567","article-title":"Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis","volume":"55","author":"Pellicoro","year":"2012","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0660","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","article-title":"Reversal of liver fibrosis: from fiction to reality","volume":"31","author":"Zoubek","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0665","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1053\/jhep.2001.28457","article-title":"Transforming growth factor \u03b2 and the liver","volume":"34","author":"Bissell","year":"2001","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmxen.2023.03.003_bib0670","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1530-0277.2010.01160.x","article-title":"Chronic alcohol consumption is associated with an increased cytotoxic profile of circulating lymphocytes that may be related with the development of liver injury","volume":"34","author":"Laso","year":"2010","journal-title":"Alcohol Clin Exp Res."}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X23000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X23000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:52:43Z","timestamp":1762419163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X23000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":134,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2255534X23000269"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2023.03.003","relation":{},"ISSN":["2255-534X"],"issn-type":[{"value":"2255-534X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver disease","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}